Subcutaneous unfractionated heparin for treatment of venous thromboembolism in end-stage renal disease.

Link to article at PubMed

Subcutaneous unfractionated heparin for treatment of venous thromboembolism in end-stage renal disease.

Ann Pharmacother. 2010 Dec;44(12):2023-7

Authors: Metzger NL, Chesson MM

To report 3 cases of venous thromboembolism (VTE) in patients with end-stage renal disease (ESRD) treated with subcutaneous unfractionated heparin (UFH) bridged with warfarin.

PMID: 21098749 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published. Required fields are marked *